Scroll To Top
Search by Speciality

Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference 2014

Hilton Hotel Orlando * | Orlando, USA
From 100 to 649 USD
Event Preview
EXPIRED
This event
is Finished
Title: Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference 2014
Specialty: , Gastroenterology
Dates: From Dec, 4, 2014 to Dec, 6, 2014
Location: Orlando, USA
Type: Conference
Registration Cost: From 100 to 649 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Dec
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for ORLANDO, Usa.
General Info
Event Venue:

Hilton Hotel Orlando *

ORLANDO, USA Visit the Venue to read more
Currency:
USD
Event Overview
Welcome message:

Our focus is to continually improve your meeting experience from the scientific content to the meeting logistics. To accommodate the growing needs of this event, the majority of past AIBD attendees selected Orlando, FL as the new location for the 2014 conference. This year's move to Orlando will allow for:

  • Larger conference space and meeting rooms
  • More hotel room availability
  • More dining options
  • More non-stop, daily flights
  • Enhanced technological capabilities
  • Expanded Meet-the-Experts sessions
  • Increased exhibit space
  • More networking opportunities

For anyone that has previously attended, we welcome you back knowing our new location will provide you with an improved experience. For new attendees, we think it is time for you to see what the excitement is all about.

Check out the 2013 Best-of-Day clips here:http://elc.imedex.com/ELC/Activity-Detail.aspx?activityid=6983. Included are highlights from Drs. Abreu, Hanauer, Markowitz, and Kelly on the basic science, nursing, and pediatric tracks.

Speakers/Faculty:

Chairs

Richard P MacDermott, MD, MACG, FACG, AGAF
Stephen B Hanauer, MD, FACG, AGAF

Clinical Organizing Committee

Athos Bousvaros, MD, MPH, FACG, AGAF
Jean Frederic Colombel, MD,
Lee A. Denson, MD
Sunanda V. Kane, MD, MSPH, FACG, AGAF
Sandra C. Kim, MD
Gary R. Lichtenstein, MD, FACG, AGAF
Uma Mahadevan, MD
Miguel Regueiro, MD, FACG, AGAF
Feza Remzi, MD
David T. Rubin, MD, FACG, AGAF
Michele Rubin, APN, CNS, CGRN
Bruce E. Sands, MD, MS, FACG, AGAF
Bo Shen, MD, FACG

 

Faculty

Maria T. Abreu, MD
Miller School of Medicine
University of Miami
Miami, Florida

Robert N. Baldassano, MD
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Millie Boettcher, MSN, CRNP, CNSN
Children’s Hospital of Philadelphia
Philadelphia, Philadelphia

Athos Bousvaros, MD, MPH
Boston Children’s Hospital
Boston, Massachusetts

Robert Burakoff, MD, MPH
Brigham and Women’s Hospital
Boston, Massachusetts

Judy H. Cho, MD
Icahn School of Medicine at Mount Sinai
New York, New York

Russell D. Cohen, MD
University of Chicago Medicine
Chicago, Illinois

Jean-Frederic Colombel, MD
Icahn School of Medicine at Mount Sinai
New York, New York

Raymond K. Cross, MD, MS, AGAF
University of Maryland School of Medicine
Baltimore, Maryland

Lee A. Denson, MD
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

Phillip R. Fleshner, MD
Cedars-Sinai Medical Center
Los Angeles, California

Sonia Friedman, MD
Brigham and Women’s Hospital
Boston, Massachusetts

Wendy Garrett, MD, PhD
Harvard Medical School
Boston, Massachusetts

Lori M. Gawron, MD, MPH
University of Utah School of Medicine
Salt Lake City, Utah

Matthew Grisham, PhD
Texas Tech University
Health Sciences Center
Lubbock, Texas

Stephen B. Hanauer, MD, FACG, AGAF
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Hans Herfarth, MD, PhD
UNC School of Medicine
Chapel Hill, North Carolina

Peter D. Higgins, MD, PhD
University of Michigan Health System
Ann Arbor, Michigan

Christian Jobin, PhD
UNC School of Medicine
Chapel Hill, North Carolina

 

Sunanda V. Kane, MD
Mayo Clinic - Rochester
Rochester, Minnesota

Sandra C. Kim, MD
Nationwide Children’s Hospital
Columbus, Ohio

Asher A. Kornbluth, MD
Icahn School of Medicine at Mount Sinai
New York, New York

Joshua R. Korzenik, MD
Brigham and Women’s Hospital
Boston, Massachusetts

James D. Lewis, MD, MSCE
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Gary R. Lichtenstein, MD
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Edward V. Loftus, Jr., MD
Mayo Clinic - Rochester
Rochester, Minnesota

Richard P. MacDermott, MD, MACG, AGAF, FACP
Albany Medical Center
Albany, New York

Scott Magness, PhD
UNC School of Medicine
Chapel Hill, North Carolina

Uma Mahadevan, MD
UCSF Medical Center
San Francisco, California

Sarkis Mazmanian, PhD
California Institute of Technology
Pasadena, California

Gil Melmed, MD, MS
Cedars-Sinai Medical Center
Los Angeles, California

Alan C. Moss, MD
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Aleixo Muise, MD, PhD
The Hospital for Sick Children
Toronto, Ontario, Canada

Mark T. Osterman, MD, MSCE
Hospital of the University of Pennsylvania
Abramson Cancer Center
Philadelphia, Pennsylvania

Miguel Regueiro, MD
University of Pittsburgh 
Pittsburgh, Pennsylvania

Feza H. Remzi, MD
Cleveland Clinic
Cleveland, Ohio

Joel R. Rosh, MD
Goryeb Children’s Hospital
Atlantic Health System
Morristown, New Jersey

David T. Rubin, MD
University of Chicago Medicine
Chicago, Illinois

Michele Rubin, APN, MSN, CNS
University of Chicago Medicine
Chicago, Illinois

William J. Sandborn, MD
UC San Diego School of Medicine
La Jolla, California

Bruce E. Sands, MD, MS
Icahn School of Medicine at Mount Sinai
New York, New York

R. Balfour Sartor, MD
UNC School of Medicine
Chapel Hill, North Carolina

Bo Shen, MD
The Cleveland Clinic
Cleveland, Ohio

Alexis Sherman, RN, BSN, CWOCN
Mount Sinai Medical Center
New York, New York

Corey A. Siegel, MD
The Dartmouth Institute for Health Policy & Clinical Practice
Lebanon, New Hampshire

Scott B. Snapper, MD, PhD
Harvard Medical School
Boston, Massachusetts

Thaddeus Stappenbeck, MD, PhD
Washington University School of Medicine
St. Louis, Missouri

Mark Sundrud, PhD
The Scripps Research Institute – Florida
Jupiter, Florida

Eva Szigethy, MD, PhD
Children’s Hospital of Pittsburgh
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

William Tremaine, MD, FACG, AGAF
Mayo Clinic - Rochester
Rochester, Minnesota

Thomas Ullman, MD, FACG, AGAF
Icahn School of Medicine at Mount Sinai
New York, New York

Fernando S. Velayos, MD, MPH
University of California – San Francisco
San Francisco, California

Daniel von Allmen, MD
Cincinnati Children’s Hospital
Cincinnati, Ohio

Betty J. White, MN, ARNP
Digestive Health Specialists
Maple Valley, Washington

Douglas C. Wolf, MD, FACG
Atlanta Gastroenterology Associates
Atlanta, Georgia

Gary D. Wu, MD
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Ramnik J. Xavier, MD, PhD
Massachusetts General Hospital
Boston, Massachusetts

Registration Not yet available Register Now
Accommodation
Accommodation:

The Hilton Orlando
6001 Destination Parkway
Orlando, Florida 32819
Tel.: +1 (407) 313-4300 
Toll Free: +1 (888) 488-3509
Fax: +1 (407) 313-4301 
www.thehiltonorlando.com

The Hilton Orlando offers an attractive location and accommodations located just 15 minutes from the Orlando International Airport. The hotel is conveniently nestled in close proximity to the International Drive shopping, dining and some of Orlando’s main attractions that include the Orange County Convention Center, SeaWorld, Universal Orlando and Wet ‘n Wild Water park. The Hilton Orlando features spectacular amenities that everyone will enjoy.

For the convenience of attendees, a room block with a limited number of rooms has been reserved at the discounted group rate of $189 single/double occupancy, plus tax, currently at 12.5%. This limited number of discounted rooms will be available until October 31, 2014 or after the room block has been filled (whichever comes first). Reservations received after October 31, 2014 or after the room block has been filled, are subject to availability and prevailing hotel rates.

To reserve your room you may contact The Hilton Orlando at +1 (407) 313-4300 or through the reservations department at orloc-eservations@hilton.com. To receive the group rate, callers must identify themselves as being with the Advances in IBD 2014 group. Reservation requests received after October 31, 2014 may not be guaranteed the group rate.

Groups

If you are bringing a group of 5 or more people, you must go through Imedex for housing. Please contact Teresa Lovich att.lovich@imedex.com or +1 (214) 679-8736.

Scientific Content Up to Date
Submission Info

We invite you to share your endeavors with the healthcare community at the Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference bysubmitting an abstract online. Submission deadline is September 1, 2014.

  • Increase Your Prestige. Seize the opportunity to present your work at one of the most highly regarded conferences in the field to over 2,000 attendees.
  • Gain added exposure for your work. Accepted abstracts will be published in the Journal of Inflammatory Bowel Diseases and scheduled for oral or poster presentation.
  • Share with your colleagues. Reception in conjunction with poster viewing encourages visibility.
  • Receive an award or grant. A limited number of travel grants are being offered to nurses, nurse practitioners, and GI fellows. The travel grant includes free registration and a $500 scholarship to cover travel. Applicants must submit an abstract to qualify. 

Participants interested in presenting data should submit abstracts online by September 1, 2014, 11:59PM ET. Abstracts are subject to acceptance by the Scientific Abstract Review Committee. Abstracts selected for presentation will be published in Inflammatory Bowel Diseases, December 2014 Supplement, and scheduled for oral or poster presentation. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on October 10, 2014.

Abstracts will be accepted in the following categories: Clinical orPediatric or Basic Science or Nursing. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

Clinical Abstracts Categories

C1. Investigator-initiated Controlled Clinical Trials
C2. Investigator-initiated Uncontrolled Clinical Trials
C3. Pharma-initiated Clinical Trials
C4. Procedures and Diagnostics
C5. Epidemiology and Outcomes Research
C6. Patient Care and Complications of Therapy
C7. Clinical Case Reports
C8. Surgery

Pediatric Clinical Abstracts Categories

P1. Investigator-initiated Controlled Clinical Trials
P2. Investigator-initiated Uncontrolled Clinical Trials
P3. Pharma-initiated Clinical Trials
P4. Procedures and Diagnostics
P5. Epidemiology and Outcomes Research
P6. Patient Care and Complications of Therapy
P7. Clinical Case Reports
P8. Pediatric Surgery

Basic Research Abstract Categories

B1. Genetics
B2. Microbiology
B3 Innate Immune System
B4. Adaptive Immune System
B5. Cytokines, Chemokines, and Cell Signaling
B6. Epithelial Cells
B7. Animal Models

Nursing Abstract Categories

N1. Clinical Education
N2. Clinical Basic Research
N3. Clinical Practice
N4. Other

Abstract Guidelines

Accepted format:

  • Abstracts must be in English
  • Word document format
  • 9 point Arial font
  • 500 word count limit
  • Use a concise title
  • List affiliations of author(s) as briefly as possible, with city, province and country
    • The system can accommodate up to 20 total authors
  • Use standard and well-accepted abbreviations
  • When listing references, use standard and well-accepted formats
  • You may upload up to three (3) associated files or graphics, as a JPG or TIFF file only, that are no larger than 5MB
  • Abstract content should be single-spaced and typed in lower case
  • Abstracts shall be of original research and contain a concise statement of study aim
  • Please include the following four (4) parts of your abstract:
    • Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable

Previous Presentation, Publication and Duplication of Abstracts

***Abstracts that will NOT be considered for presentation***

  • Abstracts that have been or will be presented before the 2014 Advances in IBD Conference
  • Abstracts that have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline
  • Abstracts that have been duplicated in any way
  • Abstracts may not be submitted to more than one category
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster or oral presentation, are eligible for submission but must contain new, additional information to be considered
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author

Presentation Formats

 

  • Oral presentations
  • Poster presentations

Abstracts for oral or poster presentations will be chosen by the Scientific Abstract Review Committee.

Oral Abstract Presentation: Oral abstracts will be 10 minute presentations, which is the total allotted time. Therefore presenters must plan accordingly to schedule audience participation and questions. Employees of commercial interests are not preferred oral abstract presenters, but authors on the abstract who are not employees of commercial interests are eligible to present their data, if selected.

Poster Abstract Presentation: Poster presentations encourage interaction and exchange between authors and attendees. Detailed information regarding presentation times will be forthcoming.

Inclusion of Quick Response (QR) Codes

A QR code (abbreviation for Quick Response Code) is a type of bar code that you can scan with your smart phone or mobile device. Data such as a PDF version of a research poster or a website’s URL pointing to an online version of the research poster is sent to your phone when you scan the code. To scan, you will need a QR code reader installed on your device, of which there are many free versions of this software available for download.

 

The conference does permit use of QR codes on printed posters in the poster hall, as long as the code facilitates the user/scanner to view:*

  • a PDF version of the poster on their mobile device (ie, ePoster), and/or
  • a website URL pointing to an online version the research poster

* Any other use of a QR code is prohibited, and violation of this policy could result in a sanction from submitting abstracts to this conference for the submitting authors and/or other restrictions from participation at this conference.

Although preliminary research1 on QR codes has demonstrated increased interactions through their use, an average of 3-5 minutes may be required of presenters to explain and demonstrate this technology.  Thus, poster presenters should be properly prepared for this possibility on site.

Additionally, the conference bears no responsibility for the generation or oversight of QR codes for any specific poster.  The decision to include, and implementation of, QR codes on specific posters is the sole responsibility of the poster presenter.

Reference:

  • J.R. Meloro, ISMPP CMPP, Kristen Letrent, PharmD, BCPS, ISMPP CMPP, Joanne C. Ryan, PhD, RN, Josephine A. Sollano, DrPH, MPH, Cate Scott, PhD. Pfizer Oncology Global Medical Communications, New York, NY, La Jolla, CA, Walton Oaks, UK. Digital Dissemination of Scientific Poster Presentations via Quick Response (QR) Codes: Implementation and Analytics Quick Response (QR) Codes: Implementation and Analytics. Presented at the 9th Annual Meeting of the International Society for Medical Publication Professionals, Baltimore, MD, USA, April 29-May 1, 2013.

Travel Grants

A limited number of travel grants will be offered to GI fellows-in-training and nurses to attend the 2014 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference.  These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

The first author must meet the following criteria to be considered for the award:

  • Candidate must submit a well-written, concise, and accurate abstract
  • Candidate must show original research of major importance in the field of medical/clinical Inflammatory Bowel Diseases conducted by themselves and co-investigators (if any)
  • Candidate must show relevance of the work to a current problem in patients involving Inflammatory Bowel Diseases
  • Candidate must be registered for the conference and present during the scheduled poster presentation times
  • For fellows-in-training, candidate for the award must be in training in a recognized GI training program. Candidate may be asked to provide a letter of support from his/her Program Director indicating their eligibility for the award

All GI fellows-in-training and nurses eligible and interested for consideration for these awards must indicate so by answering “yes” when asked during the official abstract submission process. Travel grants will be based on abstract review score as determined by the Scientific Abstract Review Committee.

Commitment to Present

Submission of an abstract constitutes a commitment by the author(s) to present if it is accepted. Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2014 Advances in IBD Conference. This conference does not provide honoraria for abstract presenters.

The conference will withdraw abstracts upon written notification from the submitting author by October 24, 2014. After this date, we cannot guarantee that a withdrawn abstract will be excluded from publication. If circumstances prevent attendance, the primary author must arrange for the presentation to be given by a co-author. Acceptance of the abstract obligates the author to present the paper.

Travel Grants

A limited number of travel grants will be offered to GI fellows-in-training, nurse practitioners and nurses to attend this conference. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

The first author must meet the following criteria to be considered for the award:

  • Candidate must submit a well-written, concise, and accurate abstract
  • Candidate must show original research of major importance in the field of medical/clinical Inflammatory Bowel Diseases conducted by themselves and coinvestigators (if any)
  • Candidate must show relevance of the work to a current problem in patients involving Inflammatory Bowel Diseases
  • Candidate must be registered for the conference and present during the scheduled poster presentation times
  • For fellows-in-training, candidate for the award must be in training in a recognized GI training program. Candidate may be asked to provide a letter of support from his/her Program Director indicating their eligibility for the award

All GI fellows-in-training, nurse practitioners, and nurses eligible and interested for consideration for these awards must indicate so by answering “yes” when asked during the official abstract submission process. Travel grants will be based on abstract review score as determined by the Scientific Abstract Review Committee.

For information on abstract guidelines and travel grants, download the PDF below:

Sponsors Exhibitors
Contact
Organising Agency

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, Georgia
30009, USA
Tel.: +1 (770) 751-7332
Fax: +1 (770) 751-7334
Email: meetings@imedex.com
www.imedex.com

Official Event Webpage
Event map
Revelant Events